It is our pleasure to share the following invitation from
Drs. Geraldina Dominguez and Robert Yarchoan
The Office of HIV and AIDS Malignancy (OHAM) in the National Cancer Institute is hosting a virtual workshop on Wednesday, October 13, 2021 from 10 AM-5:30 PM EST to discuss the need, potential, and feasibility of developing a vaccine against Kaposi sarcoma-associated herpesvirus (KSHV), also called human herpesvirus-8 (HHV-8). The focus of the workshop will be on vaccines to prevent initial infection or prevent the development of disease, NOT on a therapeutic vaccine.
If successful, development of this vaccine could prevent the development of KSHV-associated tumors and other disorders including Kaposi sarcomas (KS), primary effusion lymphoma (PEL), and KSHV-multicentric Castleman disease (KSHV-MCD). However, it has been pointed out that there would likely be challenges in developing, testing, and implementing such a vaccine. The aim of this workshop is to have a broad discussion of these issues.
Please note that this is a scientific workshop to exchange information and enhance our understanding of the issues. Its purpose is NOT to provide advice to the NCI or the NIH.
Please feel free to use the WebEx link below if you are interested in listening (will not be able to unmute and speak) to the October 13th event. The link will go live at 9:30 AM EST allowing participants to login before the start of the meeting.
Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Vaccine Workshop
Hosted by AV – Ahmadi, Amir (NIHNCI)
Wednesday, Oct 13, 2021 9:30 am | 8 hours | (UTC-04:00) Eastern Time (US & Canada)
Event number: 2302 823 8380
Event password: ZMqc32GsP@7 (96723247 from phones)
Join by phone
1-650-479-3207 Call-in toll number (US/Canada)
Access code: 230 282 38380
Attached is the latest agenda that includes the sessions and speakers in each session. If you have any questions please feel free to contact either of the co-chairs.
KSHV Vaccine Workshop Co-chairs
Dr. Geraldina Dominguez
Director, AIDS Malignancy Program
Office of HIV and AIDS Malignancy (OHAM)
Dr. Robert Yarchoan, Chief
HIV and AIDS Malignancy Branch, CCR, and
Director, Office of HIV and AIDS Malignancy (OHAM)